Safe and Affordable Drugs from Canada Act of 2025

Bill 119 s 641, also known as the Safe and Affordable Drugs from Canada Act, aims to amend the Federal Food, Drug, and Cosmetic Act to permit individuals to import safe and affordable prescription drugs from approved pharmacies in Canada. The bill seeks to address the issue of high prescription drug prices in the United States by allowing consumers to access lower-cost medications from our neighboring country.

Under the proposed legislation, individuals would be able to import prescription drugs from Canada as long as the drugs are approved by the Food and Drug Administration (FDA) and purchased from licensed pharmacies in Canada. This would provide Americans with more options for obtaining their medications at a lower cost, potentially saving them money on their healthcare expenses.

Supporters of the bill argue that allowing for the personal importation of drugs from Canada would increase competition in the pharmaceutical market, leading to lower prices for consumers. They also believe that it would provide a safe and reliable option for individuals who struggle to afford their medications in the US. Opponents of the bill, however, raise concerns about the safety and quality of imported drugs, as well as the potential impact on the US pharmaceutical industry. They argue that allowing for the importation of drugs from Canada could undermine the FDA's regulatory authority and lead to counterfeit or substandard medications entering the US market. Overall, Bill 119 s 641 presents a potential solution to the issue of high prescription drug prices in the US by allowing for the personal importation of safe and affordable drugs from approved pharmacies in Canada. The bill is currently under consideration in Congress, where it will be debated and potentially amended before a final vote is taken.